Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism

Author:

Conlon Erin G1,Fagegaltier Delphine2,Agius Phaedra3,Davis-Porada Julia1,Gregory James2,Hubbard Isabel2,Kang Kristy2,Kim Duyang2,Phatnani Hemali4,Kwan Justin5,Sareen Dhruv67,Broach James R8,Simmons Zachary9,Arcila-Londono Ximena10,Lee Edward B11,Van Deerlin Vivianna M11,Shneider Neil A12,Fraenkel Ernest13,Ostrow Lyle W14,Baas Frank15,Zaitlen Noah16,Berry James D1718,Malaspina Andrea1920,Fratta Pietro21,Cox Gregory A22,Thompson Leslie M2324,Finkbeiner Steve25,Dardiotis Efthimios26,Miller Timothy M27,Chandran Siddharthan28,Pal Suvankar28,Hornstein Eran29,MacGowan Daniel J30,Heiman-Patterson Terry31,Hammell Molly G32,Patsopoulos Nikolaos A333435,Dubnau Joshua36,Nath Avindra37,Phatnani Hemali2,Shneider Neil A38ORCID,Manley James L1ORCID,

Affiliation:

1. Department of Biological Sciences, Columbia University, New York, United States

2. Center for Genomics of Neurodegenerative Disease, New York Genome Center, New York, United States

3. New York Genome Center, New York, United States

4. Center for Genomics of Neurodegenerative Diseases, New York Genome Center, New York, United States

5. Department of Neurology, University of Maryland School of Medicine, University of Maryland ALS Clinic, Baltimore, United States

6. Cedars-Sinai Department of Biomedical Sciences, Board of Governors Regenerative Medicine Institute and Brain Program, Cedars-Sinai Medical Center, Los Angeles, United States

7. Department of Medicine, University of California, Los Angeles, United States

8. Department of Biochemistry and Molecular Biology, Penn State Institute for Personalized Medicine, The Pennsylvania State University, Hershey, United States

9. Department of Neurology, The Pennsylvania State University, Hershey, United States

10. Department of Neurology, Henry Ford Health System, Detroit, United States

11. Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States

12. Department of Neurology, Center for Motor Neuron Biology and Disease, Institute for Genomic Medicine, Columbia University, New York, United States

13. Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, United States

14. Department of Neurology, Johns Hopkins School of Medicine, Baltimore, United States

15. Department of Neurogenetics, Academic Medical Centre, Amsterdam and Leiden University Medical Center, Leiden, Netherlands

16. Department of Medicine, Lung Biology Center, University of California, San Francisco, San Francisco, United States

17. ALS Multidisciplinary Clinic, Neuromuscular Division, Department of Neurology, Harvard Medical School, Boston, United States

18. Neurological Clinical Research Institute, Massachusetts General Hospital, Boston, United States

19. Centre for Neuroscience and Trauma, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom

20. Department of Neurology, Basildon University Hospital, Basildon, United Kingdom

21. Institute of Neurology, National Hospital for Neurology and Neurosurgery, University College London, London, United Kingdom

22. The Jackson Laboratory, Bar Harbor, United States

23. Department of Psychiatry and Human Behavior and Department of Biological Chemistry, School of Medicine, University of California, Irvine, Irvine, United States

24. Department of Neurobiology and Behavior, School of Biological Sciences, University of California, Irvine, Irvine, United States

25. Taube/Koret Center for Neurodegenerative Disease Research, Roddenberry Center for Stem Cell Biology and Medicine, Gladstone Institute, San Francisco, United States

26. Department of Neurology and Sensory Organs, University of Thessaly, Thessaly, Greece

27. Department of Neurology, Washington University in St. Louis, St. Louis, United States

28. Centre for Clinical Brain Sciences, Anne Rowling Regenerative Neurology Clinic, Euan MacDonald Centre for Motor Neurone Disease Research, University of Edinburgh, Edinburgh, United Kingdom

29. Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel

30. Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, United States

31. Center for Neurodegenerative Disorders, Department of Neurology, the Lewis Katz School of Medicine, Temple University, Philadelphia, United States

32. Cold Spring Harbor Laboratory, Cold Spring Harbor, United States

33. Computer Science and Systems Biology Program, Ann Romney Center for Neurological Diseases, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, United States

34. Division of Genetics in Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, United States

35. Program in Medical and Population Genetics, Broad Institute, Cambridge, United States

36. Department of Anesthesiology, Stony Brook University, Stony Brook, United States

37. Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, United States

38. Department of Neurology, Columbia University Medical Center, New York, United States

Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) represent two ends of a disease spectrum with shared clinical, genetic and pathological features. These include near ubiquitous pathological inclusions of the RNA-binding protein (RBP) TDP-43, and often the presence of a GGGGCC expansion in the C9ORF72 (C9) gene. Previously, we reported that the sequestration of hnRNP H altered the splicing of target transcripts in C9ALS patients (Conlon et al., 2016). Here, we show that this signature also occurs in half of 50 postmortem sporadic, non-C9 ALS/FTD brains. Furthermore, and equally surprisingly, these ‘like-C9’ brains also contained correspondingly high amounts of insoluble TDP-43, as well as several other disease-related RBPs, and this correlates with widespread global splicing defects. Finally, we show that the like-C9 sporadic patients, like actual C9ALS patients, were much more likely to have developed FTD. We propose that these unexpected links between C9 and sporadic ALS/FTD define a common mechanism in this disease spectrum.

Funder

NIH Office of the Director

Amyotrophic Lateral Sclerosis Association

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3